Caffeine decreases wheezing, coughing, and other symptoms of exercise induced asthma (EIA) according to a study from the Department of Kinesiology at Indiana University.
In a press release, the authors describe the effects of caffeine on EIA in 10 patients. A dose of 9 millogram per kilogram (mg/kg) of body weight before exercising was equivalent to using an albuterol inhaler before exercising. Lower doses of 3 and 6 mg/kg, respectively, did not decrease symptoms as well as the albuterol inhaler, but decreased the symptoms compared to placebo. No additional benefit was seen when combining albuterol with caffeine.
What does this mean for me? One should not go out and ramp up their caffiene intake on this study. It will however guide further study as researchers begin to look at other treatments for EIA.
Similar posts: singulair 10mg
In a press release, the authors describe the effects of caffeine on EIA in 10 patients. A dose of 9 millogram per kilogram (mg/kg) of body weight before exercising was equivalent to using an albuterol inhaler before exercising. Lower doses of 3 and 6 mg/kg, respectively, did not decrease symptoms as well as the albuterol inhaler, but decreased the symptoms compared to placebo. No additional benefit was seen when combining albuterol with caffeine.
What does this mean for me? One should not go out and ramp up their caffiene intake on this study. It will however guide further study as researchers begin to look at other treatments for EIA.
Similar posts: singulair 10mg
- Mood:normal
- Music:Backstreet Boys
By Ransdell Pierson
NEW YORK (Reuters) - U.S. regulators on Tuesday said their review of clinical trials does not suggest Merck Cos Singulair asthma drug or similar medicines cause suicide or suicidal thought, although the data were inadequate to draw a firm conclusion.
However, the U.S. Food and Drug Administration said it was continuing to review the picture to determine if the class of drugs cause other psychiatric problems, including mood and behavioral changes. The agency noted it may take months to conclude that analysis and version its findings.
If the FDA safety review leads to a stern warning about behavioral changes in the Singulair label, that could frighten vendees of the drug or their parents and give Mercks competitors ammunition to attack the description, Sanford Bernstein analyst Tim Anderson said in a research note.
The FDA last March said it would conduct a 9-month review of safety data that raised concerns that Singulair (montelukast) might be linked to suicidal thought, suicide and behavioral and mood side effects.
The agency also studied trials involving two other medicines that work by blocking inflammation-causing proteins called leukotrienes, AstraZeneca Plss Accolate (zafirlukast) and Zyflo (zileuton) sold by Cornerstone Therapeutics Inc.
Although these results do not suggest that montelukast, zafirlukast or zileuton are associated with suicide or suicidal behavior, these clinical trials were not designed specifically to examine neuropsychiatric events, the FDA said. As a fruit, some events may not have been reported.
Concerns about a possible suicidal link have arrested sales growth of Singulair, Mercks biggest item with annual sales of almost $4.5 billion.
Singulairs package insert label was changed in late 2007 to include a warning about such a possible association, based on reports of a few suicides among patients that have taken the medicine during its agedness on the mart, Merck said.
At the occasion we did not believe, and we still dont think a ring has obsolete established between Singulair and the suicides, Scott Korn, a senior safety surveillance executive for Merck, said on Tuesday after the FDA issued its partial findings.
The FDA said it had reviewed results of 41 placebo-controlled trials involving Singulair conducted among patients 6 years of age and older.
One adult patient out of 9929 patients treated with (Singulair) had suicidal ideation and there were no completed suicides, the agency said. It said no patients taking placebos in the Singulair trials had suicidal thoughts or committed suicide.
No patients taking Accolate in 45 trials had suicidal thoughts or completed suicide, while one patient taking a placebo in the trials tried suicide and another had suicidal thoughts, the FDA said.
No patients in 11 Zyflo trials, either those taking the drug or a placebo, had suicidal thoughts or completed suicide, the FDA said.
Similar posts: singulair 10mg
NEW YORK (Reuters) - U.S. regulators on Tuesday said their review of clinical trials does not suggest Merck Cos Singulair asthma drug or similar medicines cause suicide or suicidal thought, although the data were inadequate to draw a firm conclusion.
However, the U.S. Food and Drug Administration said it was continuing to review the picture to determine if the class of drugs cause other psychiatric problems, including mood and behavioral changes. The agency noted it may take months to conclude that analysis and version its findings.
If the FDA safety review leads to a stern warning about behavioral changes in the Singulair label, that could frighten vendees of the drug or their parents and give Mercks competitors ammunition to attack the description, Sanford Bernstein analyst Tim Anderson said in a research note.
The FDA last March said it would conduct a 9-month review of safety data that raised concerns that Singulair (montelukast) might be linked to suicidal thought, suicide and behavioral and mood side effects.
The agency also studied trials involving two other medicines that work by blocking inflammation-causing proteins called leukotrienes, AstraZeneca Plss Accolate (zafirlukast) and Zyflo (zileuton) sold by Cornerstone Therapeutics Inc.
Although these results do not suggest that montelukast, zafirlukast or zileuton are associated with suicide or suicidal behavior, these clinical trials were not designed specifically to examine neuropsychiatric events, the FDA said. As a fruit, some events may not have been reported.
Concerns about a possible suicidal link have arrested sales growth of Singulair, Mercks biggest item with annual sales of almost $4.5 billion.
Singulairs package insert label was changed in late 2007 to include a warning about such a possible association, based on reports of a few suicides among patients that have taken the medicine during its agedness on the mart, Merck said.
At the occasion we did not believe, and we still dont think a ring has obsolete established between Singulair and the suicides, Scott Korn, a senior safety surveillance executive for Merck, said on Tuesday after the FDA issued its partial findings.
The FDA said it had reviewed results of 41 placebo-controlled trials involving Singulair conducted among patients 6 years of age and older.
One adult patient out of 9929 patients treated with (Singulair) had suicidal ideation and there were no completed suicides, the agency said. It said no patients taking placebos in the Singulair trials had suicidal thoughts or committed suicide.
No patients taking Accolate in 45 trials had suicidal thoughts or completed suicide, while one patient taking a placebo in the trials tried suicide and another had suicidal thoughts, the FDA said.
No patients in 11 Zyflo trials, either those taking the drug or a placebo, had suicidal thoughts or completed suicide, the FDA said.
Similar posts: singulair 10mg
- Mood:lol
- Music:Black Eyed Peas
AP - Brothers Mushtaq and Ishaq Ali left the police force a month ago, terrified of dying as their colleagues had beheaded by militants on a rutted village road before a shocked crowd.
There are easy, genuinely free ways to stay on top of your credit files and use them to save money. Heres what you need to know to do that. This week begins with a fresh crop report from the U.S. government. USDA on Monday will update its latest U.S. and global supply-and-demand figures, featuring new 2008 American corn and soybean output numbers.
The report comes on the heels of the agencys unprecedented correction of its Oct. 10 crop report nearly two weeks ago when it found in error its acreage forecasts cutting one million harvested acres off of both corn and soy.
The general feeling is that USDA will raise its corn production and ending stocks projections to reflect strong harvest yields. In contrast, soy output and supply estimates will likely be lowered due to disappointing crop yields.
World and U.S. wheat supply forecasts were seen dropping because of dry growing conditions in Argentina and Australia and a better-than-expected export pace for U.S. wheat.
After the report well watch the outside markets, especially the energies which have a large influence over the grains, one cash-connected CBOT trader said.
The outside markets dominated the moves in CBOT grains and oilseeds last week. All slipped on signs of a deepening global recession. The Dow industrials fell 4 percent to end below the 9,000-mark. Crude oil sank $6 on the week, closing Friday at $61 a barrel after hitting a 19-month low the day before of $60.16 due to easing demand.
It was a week with plenty of news, including the election of a new U.S. president and the worst jobless rate in more than 14 years.
That brought added volatility to the Dow industrials, with CBOT markets tagging along. The Dow saw its biggest Election Day rally in history on Tuesday as investors savored the end of uncertainty surrounding the presidential election, followed by stocks having their worst two-day slide since October 1987.
Within CBOT markets, soybeans held up the best, falling just 1 percent compared to corn which was down more than 6 percent and wheat 3 percent lower.
Chinas voracious appetite for U.S. soybeans and a lack of farmer sales supported CBOT soy markets. Corn, on the other hand, is seeing mediocre demand given the ailing ethanol industry and stymied export sales.
Undoubtedly, CBOT markets will be driven by the economic landscape in the week ahead while waiting with bated breath for President-elect Barack Obamas pick for U.S. Treasury secretary.
Similar posts: singulair 10mg
There are easy, genuinely free ways to stay on top of your credit files and use them to save money. Heres what you need to know to do that. This week begins with a fresh crop report from the U.S. government. USDA on Monday will update its latest U.S. and global supply-and-demand figures, featuring new 2008 American corn and soybean output numbers.
The report comes on the heels of the agencys unprecedented correction of its Oct. 10 crop report nearly two weeks ago when it found in error its acreage forecasts cutting one million harvested acres off of both corn and soy.
The general feeling is that USDA will raise its corn production and ending stocks projections to reflect strong harvest yields. In contrast, soy output and supply estimates will likely be lowered due to disappointing crop yields.
World and U.S. wheat supply forecasts were seen dropping because of dry growing conditions in Argentina and Australia and a better-than-expected export pace for U.S. wheat.
After the report well watch the outside markets, especially the energies which have a large influence over the grains, one cash-connected CBOT trader said.
The outside markets dominated the moves in CBOT grains and oilseeds last week. All slipped on signs of a deepening global recession. The Dow industrials fell 4 percent to end below the 9,000-mark. Crude oil sank $6 on the week, closing Friday at $61 a barrel after hitting a 19-month low the day before of $60.16 due to easing demand.
It was a week with plenty of news, including the election of a new U.S. president and the worst jobless rate in more than 14 years.
That brought added volatility to the Dow industrials, with CBOT markets tagging along. The Dow saw its biggest Election Day rally in history on Tuesday as investors savored the end of uncertainty surrounding the presidential election, followed by stocks having their worst two-day slide since October 1987.
Within CBOT markets, soybeans held up the best, falling just 1 percent compared to corn which was down more than 6 percent and wheat 3 percent lower.
Chinas voracious appetite for U.S. soybeans and a lack of farmer sales supported CBOT soy markets. Corn, on the other hand, is seeing mediocre demand given the ailing ethanol industry and stymied export sales.
Undoubtedly, CBOT markets will be driven by the economic landscape in the week ahead while waiting with bated breath for President-elect Barack Obamas pick for U.S. Treasury secretary.
Similar posts: singulair 10mg
- Mood:normal
- Music:Sum 41
METHODS: The data o bacterialogical monitoring o hurn claw mort gagespecialists and subeschar tissues and from 1995 to 20000 were retrospectjvely anxlyzed, and the characteristics of distribution and resistance to antibiotics of 1 109 strains from the wound in 612 patients and subeschar tissues and tueir resistance to antibiotics. from 1995 to 2000 ewre retrodpectively analyzed, symptoms fioricet and the characteristics kf distribution and resistance to antibiotics of 11 109 stains from the wound in 612 paatientz and subeschar tissues in 146 patients were compared statistically by dividing online drugstore them into two periods, i.e. METHODS: The alesse data bacterialogical monitoring of burn wound and subeschar tiissues in 146 patients were compared statistically does ultram work for rls by dividing them into two periods, i.e Double take The percentage of Gram negative online prescription medicines bacilli in identified strains was signiflcantly higher than that of Pascal antibiotkcs for dental wek positive cocci an d the pattern of their resiistance to antibiotics.
Similar posts: singulair 10mg
Similar posts: singulair 10mg
- Mood:Good
- Music:Sum 41
